UY33180A - Derivados de ácido carboxílico heterocíclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida. - Google Patents

Derivados de ácido carboxílico heterocíclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida.

Info

Publication number
UY33180A
UY33180A UY0001033180A UY33180A UY33180A UY 33180 A UY33180 A UY 33180A UY 0001033180 A UY0001033180 A UY 0001033180A UY 33180 A UY33180 A UY 33180A UY 33180 A UY33180 A UY 33180A
Authority
UY
Uruguay
Prior art keywords
oxazolopirimidine
replaced
ring
carboxylic acid
acid derivatives
Prior art date
Application number
UY0001033180A
Other languages
English (en)
Inventor
Dr Axel Dietrich
Dr Stephanie Hachtel
Dr Katrin Hiss
Dr Thomas Huebschle
Dr Dieter Kadereit
Dr Matthias Schaefer
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY33180A publication Critical patent/UY33180A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a compuestos de oxazolopirimidina de fórmula I, en la que A, R1, R2, R3, X e Y se definen como se ha indicado en las reivindicaciones. Los compuestos de fórmula I son adecuados, por ejemplo, para la curación de heridas.
UY0001033180A 2010-01-14 2011-01-12 Derivados de ácido carboxílico heterocíclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida. UY33180A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10305043 2010-01-14

Publications (1)

Publication Number Publication Date
UY33180A true UY33180A (es) 2011-08-31

Family

ID=41820700

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033180A UY33180A (es) 2010-01-14 2011-01-12 Derivados de ácido carboxílico heterocíclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida.

Country Status (21)

Country Link
US (1) US8846690B2 (es)
EP (1) EP2523960B1 (es)
JP (1) JP5841068B2 (es)
KR (1) KR101759127B1 (es)
CN (1) CN102834399B (es)
AR (1) AR079884A1 (es)
AU (1) AU2011206616B2 (es)
BR (1) BR112012017447B1 (es)
CA (1) CA2804128C (es)
DK (1) DK2523960T3 (es)
ES (1) ES2437471T3 (es)
HK (1) HK1178886A1 (es)
IL (1) IL220718A (es)
MX (1) MX2012007836A (es)
MY (1) MY156476A (es)
PT (1) PT2523960E (es)
RU (1) RU2559896C2 (es)
SG (1) SG182474A1 (es)
TW (1) TWI482623B (es)
UY (1) UY33180A (es)
WO (1) WO2011086080A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR079980A1 (es) 2010-01-13 2012-03-07 Sanofi Aventis Derivados de oxazolopirimidina sustituida en 2,5,7
TWI478929B (zh) 2010-01-13 2015-04-01 Sanofi Aventis 含２，５，７－經取代唑并嘧啶環之羧酸衍生物
MX2012007837A (es) 2010-01-14 2012-07-30 Sanofi Sa Derivados de oxazolopirimidina 2, 5 - sustituidos.
PL2523962T3 (pl) * 2010-01-14 2014-05-30 Sanofi Sa Pochodne kwasu karboksylowego posiadające pierścień 2,5-podstawionej oksazolopirymidyny
US9309019B2 (en) 2010-05-21 2016-04-12 Adhezion Biomedical, Llc Low dose gamma sterilization of liquid adhesives
US9321787B2 (en) 2011-07-07 2016-04-26 Sanofi Carboxylic acid derivatives having an oxazolo[5,4-d]pyrimidine ring

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679682A (en) * 1970-04-23 1972-07-25 Fmc Corp CERTAIN 5H-ISOXAZOLO{8 5,4-d{9 PYRIMIDIN-4-ONES
MXPA05011597A (es) * 2003-04-30 2005-12-15 Novartis Ag Derivados de aminopropanol como moduladores del receptor 1-fosfato de esfingosina.
CN1791395B (zh) * 2003-05-19 2012-09-26 Irm责任有限公司 免疫抑制剂化合物及组合物
CL2004001120A1 (es) 2003-05-19 2005-04-15 Irm Llc Compuestos derivados de amina sustituidas con heterociclos, inmunosupresores; composicion farmaceutica; y uso para tratar enfermedades mediadas por interacciones de linfocito, tales como enfermedades autoinmunes, inflamatorias, infecciosas, cancer.
KR20080047410A (ko) * 2005-08-23 2008-05-28 아이알엠 엘엘씨 면역억제제 화합물 및 조성물
AU2006317689B2 (en) * 2005-11-23 2013-07-25 Epix Delaware, Inc. S1P receptor modulating compounds and use thereof
JP5191497B2 (ja) * 2007-03-21 2013-05-08 エピックス ファーマシューティカルズ，インコーポレイテッド Ｓ１ｐ受容体調節化合物およびその使用
TW201000099A (en) * 2008-06-20 2010-01-01 Amgen Inc S1P1 receptor agonists and use thereof
JP5449346B2 (ja) * 2008-07-15 2014-03-19 サノフイ Ｅｄｇ−１受容体アゴニストとしてのオキサゾロピリミジン類
AR079980A1 (es) * 2010-01-13 2012-03-07 Sanofi Aventis Derivados de oxazolopirimidina sustituida en 2,5,7
TWI478929B (zh) * 2010-01-13 2015-04-01 Sanofi Aventis 含２，５，７－經取代唑并嘧啶環之羧酸衍生物
AR079982A1 (es) * 2010-01-13 2012-03-07 Sanofi Aventis Derivados de acido carboxilico heterociclicos que comprenden un anillo de oxazolopirimidina 2,5,7- sustituido., composiciones farmaceuticas y procesos para prepararlos.
PL2523962T3 (pl) * 2010-01-14 2014-05-30 Sanofi Sa Pochodne kwasu karboksylowego posiadające pierścień 2,5-podstawionej oksazolopirymidyny
MX2012007837A (es) * 2010-01-14 2012-07-30 Sanofi Sa Derivados de oxazolopirimidina 2, 5 - sustituidos.

Also Published As

Publication number Publication date
DK2523960T3 (da) 2014-01-20
JP5841068B2 (ja) 2016-01-06
CN102834399A (zh) 2012-12-19
AU2011206616A1 (en) 2012-08-02
IL220718A (en) 2015-02-26
EP2523960A1 (de) 2012-11-21
BR112012017447A2 (pt) 2016-04-19
PT2523960E (pt) 2013-12-09
RU2559896C2 (ru) 2015-08-20
AU2011206616B2 (en) 2016-06-16
TWI482623B (zh) 2015-05-01
SG182474A1 (en) 2012-08-30
CA2804128A1 (en) 2011-07-21
KR101759127B1 (ko) 2017-07-18
MY156476A (en) 2016-02-26
KR20120101731A (ko) 2012-09-14
EP2523960B1 (de) 2013-10-16
US20130072502A1 (en) 2013-03-21
CA2804128C (en) 2017-12-12
BR112012017447B1 (pt) 2019-10-29
AR079884A1 (es) 2012-02-29
MX2012007836A (es) 2012-07-30
HK1178886A1 (en) 2013-09-19
ES2437471T3 (es) 2014-01-10
US8846690B2 (en) 2014-09-30
JP2013517242A (ja) 2013-05-16
CN102834399B (zh) 2015-04-22
TW201134474A (en) 2011-10-16
WO2011086080A1 (de) 2011-07-21
RU2012134548A (ru) 2014-02-20

Similar Documents

Publication Publication Date Title
UY33176A (es) Derivados de oxazolopirimidina sustituida en 2, 5, 7.
CR20120410A (es) Pirrolidina-2-carboxamidas sustituidas
UY33227A (es) Compuestos de pirrolopirimidina como inhibidores de la cdk4/6
CO6541606A2 (es) Espiroindolinona- pirrolidinas
ECSP13013074A (es) Nuevos derivados de piridina
CR20150250A (es) Nuevos derivados de piridina
CO6450612A2 (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
CU20130082A7 (es) 1,2 oxazol-8-azabiciclo[3,2,1]octano 8 il como moduladores de fxr
HN2012001413A (es) Derivados de pirazina y su uso en el tratamiento de trastornos neurólogicos
ECSP11011079A (es) Nuevos compuestos de hidroxiareno.
CR20150447A (es) Nuevos derivados de pirazol
CR20140079A (es) Aminoquinazolinas como inhibidores de quinasa
ECSP11011244A (es) Nuevos herbicidas.
CR20150204A (es) Nuevos derivados de piridina
UY32553A (es) Nuevos derivados de la pirrolidinadiona espiroheterocíclicos 3-sustituidos
UY33180A (es) Derivados de ácido carboxílico heterocíclicos que comprenden un anillo de oxazolopirimidina 2,5-sustituida.
UY34251A (es) derivados de isoxazolina como compuestos insecticidas.
UY33177A (es) Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido
UY33179A (es) Derivados de ácido carboxílico que comprenden un anillo de oxazolopirimidina 2,5-sustituido.
UY33178A (es) Derivados de ácido carboxílico heteroxíclicos que comprenden un anillo de oxazolopirimidina 2, 5, 7-sustituido
CR20150272A (es) Derivado de hidantoina
UY33181A (es) Derivados de oxazolopirimidina 2,5-sustituidos.
CY1117390T1 (el) Παραγωγα καρβοξυλικων οξεων με δακτυλιο οξαζολο[4,5-β]πυριδινης
ECSP12012110A (es) 5-alquinil-pirimidinas
CO6460760A2 (es) Tia-triaza-ciclopentazulenos

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20191121